Product Information
ATORVASTATIN 40 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0379 per EA under NDC 00378395205. Its NADAC has been published 657 times since Dec 5, 2013.
Strength
40 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378395205
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA091226On Market Since
5/29/2012
Pharmacological Classes
Price Statistics
The NADAC for ATORVASTATIN 40 MG TABLET has been published 657 times since Dec 5, 2013, and over the history we have for it it has declined 79.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0379 per EA |
|---|---|
| All-time high | $0.1834 (Dec 11, 2013) |
| All-time low | $0.0379 (Jun 17, 2026) |
| 52-week high | $0.0463 |
| 52-week low | $0.0379 |
| Median price | $0.0887 |
| Average price | $0.0939 |
| Largest weekly change | +27.7% (Aug 21, 2024) |
| Weeks tracked | 657 |
| Tracking since | Dec 5, 2013 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ATORVASTATIN 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 40 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.0379 per EA (NDC 00378395205), effective Jul 1, 2026.
How has the price of ATORVASTATIN 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATORVASTATIN 40 MG TABLET has declined 79.4%. It has been tracked across 657 weekly CMS publications since Dec 5, 2013.
What are the highest and lowest recorded NADAC prices for ATORVASTATIN 40 MG TABLET?
Since Dec 5, 2013, the NADAC for ATORVASTATIN 40 MG TABLET has ranged from a low of $0.0379 (Jun 17, 2026) to a high of $0.1834 (Dec 11, 2013), with a median of $0.0887 per EA.
Are there cheaper alternatives to ATORVASTATIN 40 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as ATORVASTATIN 40 MG TABLET, but none are currently priced below it.
Who manufactures ATORVASTATIN 40 MG TABLET?
ATORVASTATIN 40 MG TABLET (NDC 00378395205) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification